FDA Drug Application (202033) for METOPROLOL SUCCINATE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202033
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 25MG TARTRATE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMETOPROLOL SUCCINATE
Active IngredientMETOPROLOL SUCCINATE

Active IngredientCount
List of drugs with Active Ingredient METOPROLOL SUCCINATE3


Back to FDA Applications sponsored by MYLAN PHARMS INC